News
Pfizer Canada and BioNTech Receive Health Canada Approval of LP.8.1 Variant Adapted COVID-19 Vaccine
Pfizer Canada ULC and BioNTech SE (Nasdaq: BNTX) "BioNTech" announced today that Health Canada has authorized the LP.8.1 ...
Pfizer's Canadian unit and BioNTech said they have received approval in Canada for their updated Comirnaty Covid-19 vaccine. The companies said Monday the updated vaccine targets the Omicron LP.8.1 ...
22h
Investor's Business Daily on MSNBioNTech ADR Meets 80-Plus Relative Strength Rating Benchmark
BioNTech ADR earns the No. 143 rank among its peers in the Medical-Biomed/Biotech industry group. Aurinia Pharmaceuticals ...
The top executives running the health care industry’s blue-chip companies amassed generational wealth in 2024, even as many ...
For the first time in 30 years, the American Academy of Pediatrics is substantially diverging from U.S. government vaccine ...
Texas school districts are coming back from summer with a rising number of parents asking for vaccine exemption forms and a ...
Discover how rising healthcare spending can be turned into income growth. Build a retirement portfolio that thrives in a key ...
GSK and CureVac will together receive $740 million, as well as royalties on sales of COVID-19 vaccines in the US ...
16h
TipRanks on MSNPfizer Canada, BioNTech get Health Canada approval for COVID variant vaccine
Pfizer Canada (PFE) and BioNTech (BNTX) announced that Health Canada has authorized the LP.8.1 variant adapted COMIRNATY COVID-19 vaccine for ...
Scientists say HHS’ decision to defund mRNA vaccine research will leave the country less prepared for pandemics, and make it ...
Heading into the respiratory illness season, states and clinicians are working to encourage pregnant patients to get COVID-19 ...
The U.S. government announced funding cuts to mRNA vaccine research. What is the impact on American healthcare and biotech?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results